Gamfexine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 7273-99-6 ![]() |
PubChem (CID) | 31041 |
ChemSpider | 28799 ![]() |
UNII | 3U2V80KPAL ![]() |
KEGG | D04298 ![]() |
Chemical and physical data | |
Formula | C17H27N |
Molar mass | 245.402 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Gamfexine (WIN-1,344) is a centrally acting stimulant drug, which was tested as an adjunct treatment for withdrawn patients with schizophrenia, but while effective for treating withdrawal it made psychotic symptoms worse.[1]
See also[edit]
References[edit]
- ^ John H Biel. Annual Reports in Medicinal Chemistry, Volume 2. Academic Press 1966. p18.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Gamfexine&oldid=763877125"